INNV Pharma Expands its Executive Management Team
Post# of 405
(Total Views: 363)
Posted On: 01/26/2017 11:24:10 AM
INNV Pharma Expands its Executive Management Team
Innovus Pharmaceuticals, Inc. ("Innovus Pharma"
(OTCQB Venture Market: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that Randy Berholtz will join the management team as Executive Vice President, Corporate Development and General Counsel effective January 9, 2017. A life sciences business and legal veteran with decades of experience, Berholtz joins Innovus Pharma to expand its corporate development efforts to find and enter into additional collaborations to expand the breadth and depth of product offerings on a worldwide basis.
“I am very excited to bring on Randy at this important period of commercial growth for Innovus Pharma,” said Dr. Bassam Damaj, Innovus’ Chief Executive Officer. “His business, legal and deal-making expertise and experience will help us to increase our capacity to find, negotiate with and enter into additional acquisitions and partnerships that will help us increase our product offerings and expand our international commercialization efforts to take our company to the next stage.”
Innovus Pharmaceuticals, Inc. ("Innovus Pharma"
(OTCQB Venture Market: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that Randy Berholtz will join the management team as Executive Vice President, Corporate Development and General Counsel effective January 9, 2017. A life sciences business and legal veteran with decades of experience, Berholtz joins Innovus Pharma to expand its corporate development efforts to find and enter into additional collaborations to expand the breadth and depth of product offerings on a worldwide basis. “I am very excited to bring on Randy at this important period of commercial growth for Innovus Pharma,” said Dr. Bassam Damaj, Innovus’ Chief Executive Officer. “His business, legal and deal-making expertise and experience will help us to increase our capacity to find, negotiate with and enter into additional acquisitions and partnerships that will help us increase our product offerings and expand our international commercialization efforts to take our company to the next stage.”
(0)
(0)